advanced infusion solutions lawsuit

2012) (internal quotations omitted)). write five sentence and underline the verb paul gigot missing. We have designed private, spacious, comfortable, and relaxing suites which include: Heated massage chairs. We have the following opinions for this case: This docket was last retrieved on October 25, 2021. Yes. Advanced Infusion Solutions. 1 star. 28 U.S.C. Plaintiff / Appellant: Randy Denning. Physical address: Carr. Blue Cross Blue Shield of Michigan v. Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions, US District Court for the Eastern District of Michigan, Minute Entry for proceedings before District Judge Denise Page Hood: Motion Hearing held on 6/23/2021 re #18 MOTION to Dismiss Plaintiff's Amended Complaint filed by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Disposition: Motion taken under advisement (Court Reporter: Sheri Ward) (LSau). 4:22-CV-12577 | 2022-10-26, U.S. District Courts | Contract | NOA filed by Appellant Mr. Randy Denning. cecl for dummies; can you transfer doordash credits to another account; advanced infusion solutions lawsuit; June 22, 2022 . Release of Transcript Restriction set for 10/4/2021. (Winsten, I.) [21-30534] (SEP) [Entered: 09/14/2021 03:22 PM], APPEARANCE FORM FILED by Attorney(s) Charles H. Spencer-Davis for party(s) Appellee Bond Pharmacy, Incorporated, in case 21-30534. 2:23-CV-10279 | 2023-02-02, U.S. District Courts | Contract | (Entered: 03/04/2021), Docket(#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. The basis for the action "lies in a promise, which is implied in law, that one will pay to the person entitled thereto [that] which in equity and good conscience is his." Redaction Request due 7/27/2021. [21-30534] REVIEWED AND/OR EDITED - The original text prior to review appeared as follows: UNOPPOSED MOTION filed by Appellant Mr. Randy Denning to supplement the record on appeal with Reasons in Support of Order granting Motion to Dismiss [9692325-2]. P. 57. 2009). Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions Case Summary On 01/11/2021 Blue Cross Blue Shield of Michigan filed a Contract - Insurance lawsuit against Bond Pharmacy, Inc d/b/a Advanced Infusion Solutions. (Entered: 01/28/2021), Docket(#5) NOTICE of Appearance by I. W. Winsten on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Get free access to the complete judgment in Bond Pharmacy v. Advanced Health Sys. [21-30534] (See Fifth Circuit's order transmitted separately this date) (AGL) [Entered: 10/22/2021 08:24 AM], The Motion to supplement the record on appeal filed by Appellant Mr. Randy Denning in 21-30534 [ # 9692325-2 ] has been made sufficient. (Entered: 04/08/2021), Docket(#17) STIPULATED ORDER Regarding Motions. In reviewing a motion under Federal Rule of Civil Procedure 12(b)(6), "the central issue is whether, in the light most favorable to the plaintiff, the complaint states a valid claim for relief." Request information Accepting these allegations as true, BCBS and AHS have plausibly stated both elements for breach of contract. Access this case on the Michigan Eastern District Court's Electronic Court Filings (ECF) System. This Court dismissed the ERISA claims. Id. No. Good faith means "the faithfulness of an agreed purpose between two parties, a purpose which is consistent with justified expectations of the other party." (LSau) (Entered: 04/06/2021), (#10) NOTICE of Appearance by Paul Anthony Werner, III on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. (877) 443-4006. The current location address for Advanced Infusion Solutions is 18451 Dallas Pkwy Ste 125, , Dallas, Texas and the contact number is 877-443-4006 and fax number is --. One of the HCPCS procedure codes in the Agreement is "HCPCS Code S9328". By continuing to use this website, you agree to UniCourts General Disclaimer, Terms of Service, Steury v. Cardinal Health, Inc.,625 F.3d 262, 266 (5th Cir. Defendant / Appellee: Bond Pharmacy, Incorporated, doing business as Advanced Infusion Care, doing business as Advanced Infusion Solutions, doing business as AIS Healthcare. Transcript order due on 09/23/2021, for Appellant Randy Denning. "To show Because the Counterclaim provides enough particularity to provide AIS with notice, the Court denies AIS's motion on this claim. Electronic ROA deadline satisfied. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) February 7, 2022. Call us at (425) 485-6059. to Dismiss [57] at 11-12; [46] 31. Lead Counsel? Advanced Infusion Solutions provides pharmacy services. (Entered: 03/04/2021), (#7) ORDER for Extension of Time to Respond to Complaint #1 , ( Response due by 3/4/2021) Signed by District Judge Denise Page Hood. The practitioner's primary taxonomy code is 3336H0001X with license number 04274/2.0 (MS). Human Drug Compounding, Recalls, Market Withdrawals and Safety Alerts, Compounding Quality Center of Excellence On-demand Training, Compounding Oversight and Compliance Actions, Compounding: Inspections, Recalls, and other Actions, Consumer and Health Care Professional Information, Guidance, Compliance, & Regulatory Information, 2014 - 2015 Compounding: Inspections, Recalls, and other Actions, Referral Letter to the California State Board of Pharmacy Issued 07/06/2020, Referral Letter to the Florida State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Virginia State Board of Pharmacy dated 01/29/2020, Referral Letter to the Missouri Board of Pharmacy dated 06/16/2022, Referral Letter to the Nevada State Board of Pharmacy dated 07/13/2022, Referral Letter to the Virginia State Board of Pharmacy Issued 06/08/2017, Referral Letter to the New York State Board of Pharmacy Issued 05/08/2017, Referral Letter to the Delaware State Board of Pharmacy Issued 04/28/2017, Referral Letter to Florida State Board of Pharmacy Issued 10/09/2015, Referral Letter to the New York State Board of Pharmacy Issued 03/22/2017, Referral Letter to Florida Board of Pharmacy Issued 02/21/2014, Referral Letter to State of New Hampshire Board of Pharmacy Issued 06/07/2016, Referral Letter to the Kansas State Board of Pharmacy Issued 03/06/2019, Referral Letter to the North Carolina State Board of Pharmacy Issued 08/19/2019, Referral Letter to the Arizona State Board of Pharmacy Issued 04/09/2020, Referral to the Rhode Island State Board of Pharmacy Issued 07/25/2017, Referral Letter to the California State Board of Pharmacy Issued 08/31/2017, Referral to the New York State Board of Pharmacy Issued 11/16/2017, Referral Letter to the Mississippi Board of Pharmacy Issued 08/02/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 10/29/2019, Referral Letter to the Ohio State Board of Pharmacy Issued 05/01/2019, Referral Letter to the Florida Board of Pharmacy Issued on 01/31/17, Referral Letter to the Georgia State Board of Pharmacy Issued 11/18/2019, Referral to the Connecticut State Board of Pharmacy Issued 07/12/2017, Referral Letter to the Louisiana Board of Pharmacy Issued 11/03/2022, Referral Letter to the Michigan Board of Pharmacy Issued 03/22/2017, Referral Letter to the Ohio State Board of Pharmacy Issued 08/09/17, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 01/17/17, Referral Letter to the California State Board of Pharmacy Issued 07/20/2020, FDA Alerts Health Care Professionals and Patients not to Use Sterile Drug Products from Chen Shwezin Inc., dba Park Compounding Pharmacy, Referral Letter to the Michigan Board of Pharmacy Issued 09/09/16, Referral Letter to the Ohio Board of Pharmacy Issued 05/30/2014, Referral Letter to the Mississippi State Board of Pharmacy Issued 11/05/2019 Shutdown Letter, Referral Letter to the Mississippi Board of Pharmacy Issued 06/27/2019, Referral Letter to the Georgia State Board of Pharmacy Issued 02/15/2017, Referral Letter to the Indiana State Board of Pharmacy Issued 10/02/2019, Referral Letter to the Arkansas State Board of Pharmacy Issued 10/28/2020, Referral Letter to the California State Board of Pharmacy Issued 12/14/2015, Leader of $17 Million Health Insurance Fraud Scheme Ordered to Prison, Referral Letter to the Texas State Board of Pharmacy Issued 05/18/2020, FDA Requested Recall Letter Issued 09/09/2014, FDA Requested Recall Letter Issued 07/26/2013, Referral Letter to New Jersey State Board of Pharmacy Issued 02/21/2014, Referral Letter to the Georgia State Board of Pharmacy Issued 05/19/2020, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/29/2019, FDA warns patients and health care professionals not to use sterile products from North American Custom Laboratories LLC, dba FarmaKeio Superior Custom Compounding, Referral Letter to Missouri Board of Pharmacy Issued 02/26/2014, Referral Letter to the Alaska State Board of Pharmacy dated 02/18/2020, Referral Letter to the Alaska State Board of Pharmacy dated 02/06/2020, Referral Letter to the Tennessee Board of Pharmacy Issued 02/08/2017, FDAs Investigation into Guardians Compounded Triamcinolone-Moxifloxacin Drug Product, FDA Alerts Health Care Professionals of Adverse Events Associated with Guardians Compounded Triamcinolone and Moxifloxacin Product for Intravitreal Injection, Corrected (No Redactions) 483 Issued 10/21/2016, Referral Letter to the Texas State Board of Pharmacy Issued 03/24/2021, Referral to the California State Board of Pharmacy Issued 09/26/2017, Referral Letter to the Michigan State Department of Licensing and Regulatory Affairs (LARA) Issued 05/21/2015, Referral Letter to the Florida State Board of Pharmacy Issued 01/23/2017, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 03/27/2014, Referral Letter to the Texas State Board of Pharmacy Issued 05/05/2016, Referral Letter to the Maryland State Board of Pharmacy Issued 08/23/2019, A Case of Hemorrhagic Occlusive Retinal Vasculitis (HORV) Following Intraocular Injections of a Compounded Triamcinolone, Moxifloxacin, and Vancomycin Formulation, FDA Investigates Two Serious Adverse Events Associated with ImprimisRxs Compounded Curcumin Emulsion Product for Injection, Investigation Memo and Attachments, 08/16/2011, Referral Letter to the Minnesota State Board of Pharmacy Issued 07/01/2019, Referral to the South Carolina State Board of Pharmacy Issued 09/13/2017, Referral Letter to the Ohio Board of Pharmacy Issued 03/28/2019, Referral Letter to the ColoradoBoard of Pharmacy Issued 12/23/2020, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 10/03/2019, Referral Letter to the New Mexico State Board of Pharmacy Issued 08/22/2017, Maxor National Pharmacy Services Corporation, Referral Letter to the Texas Board of Pharmacy Issued 03/18/2014, Alexandria Medical Arts Pharmacy & Compounding Laboratory, Referral Letter to the Florida Board of Pharmacy Issued 04/21/2017, FDA announces Glades Drugs nationwide voluntary recall of Compounded Multivitamins containing High Amounts of Vitamin D3 (Cholecalciferol), Referral Letter to the California State Board of Pharmacy Issued 12/06/2019, Referral Letter to the Missouri State Board of Pharmacy Issued 01/10/2017, Referral Letter to the Missouri State Board of Pharmacy Issued 03/10/2016, Referral Letter to the Ohio State Board of Pharmacy Issued 08/11/2015, Referral Letter to the Illinois State Board of Pharmacy Issued 09/11/2019, Referral Letter to the New York State Board of Pharmacy Issued 11/15/2019, Referral Letter to the California State Board of Pharmacy Issued 11/22/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 07/11/2019, Referral Letter to Oklahoma State Board of Pharmacy Issued 02/25/2014, Referral Letter to the New York State Board of Pharmacy Issued 06/06/2019, Referral Letter to the Massachusetts Department of Public Health Issued 10/14/2015, Referral to the New York State Education Department, Office of the Professions, Pharmacy Issued 07/07/2017, Referral Letter to the Minnesota State Board of Pharmacy Issued 04/10/2019, Referral Letter to the Oklahoma State Board of Pharmacy Issued 10/2/2020, Referral Letter to the Missouri Board of Pharmacy Issued 02/18/2015, FDA Requested Recall Letter Issued 05/03/2016, Referral Letter to the South Carolina State Board of Pharmacy Issued 05/21/2015, Referral to the Texas State Board of Pharmacy Issued 07/28/2017, State Referral Letter to the Nevada State Board of Pharmacy issued 12/06/2017, Referral Letter to Massachusetts Board of Registration in Pharmacy Issued 01/20/2016, Barclay Luke & Pillai Specialty Pharmacy PLLC, Referral Letter to the Arizona State Board of Pharmacy Issued 05/23/2017, Referral Letter to the Michigan State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Tennessee Board of Pharmacy Issued 04/05/2017, Referral Letter to the Wisconsin State Board of Pharmacy Issued 06/13/2019, Referral Letter to the Nebraska State Board of Pharmacy Issued 05/09/2016, Unlicensed Pharmacy Technician Sentenced for Working at New England Compounding Center, Owner and Four Former Employees of New England Compounding Center Convicted Following Trial, Unlicensed Pharmacy Technician Pleads Guilty to Working at New England Compounding Center, Compounding Pharmacy Owner Sentenced to Five Years in Prison for $10.5 Million Health Care Fraud, Multistate outbreak of fungal meningitis and other infections, Referral to the Massachusetts State Board of Registration in Pharmacy Issued 09/26/2017, Referral Letter to New Hampshire State Board of Pharmacy Issued 04/29/2015, Referral Letter to the Kentucky State Board of Pharmacy Issued 03/04/2020, Referral to the Kansas State Board of Pharmacy Issued 06/28/2017, Referral Letter to the Illinois State Board of Pharmacy Issued 07/01/2020, Referral Letter to the Illinois State Board of Pharmacy Issued 10/31/2019, Referral Letter to the California State Board of Pharmacy Issued 07/08/2020, Referral Letter to Florida State Board of Pharmacy Issued 03/10/2021, Amended 483 and Cover Letter Issued 04/09/2013 and 483 Issued 03/29/2013, Referral Letter to the Tennessee State Board of Pharmacy Issued 09/13/2019, Referral Letter to the Florida State Board of Pharmacy Issued 04/22/2019, Referral Letter to the Pennsylvania State Board of Pharmacy Issued 05/05/2017, Pentec Health Announces Limited Voluntary Recall of Certain Compounded Prescription Therapies for Renal Patients, Referral Letter to the Texas State Board of Pharmacy Issued 03/12/2019, Referral Letter to the Kansas State Board of Pharmacy Issued 03/29/2017, Pharmacy Creations Issues Voluntary Recall of Four Product Lots With Limited Distribution in Florida, New Jersey, New York, and Puerto Rico Due to Potential Non-Sterility (09/04/2014), Referral Letter to the Indiana State Board of Pharmacy Issued 03/06/2017, Pharmacy Owner and Director of Compliance Charged with Defrauding United States and Distributing Adulterated Drugs, Referral Letter to the New Jersey State Board of Pharmacy Issued 07/29/2019, Referral to the Oklahoma State Board of Pharmacy Issued 07/28/2017, Referral Letter to the Georgia State Board of Pharmacy Issued 08/14/2020, Referral Letter to New York State Board of Pharmacy Issued 11/07/2016, Referral Letter to the New Jersey State Board of Pharmacy Issued 01/11/2017, Referral Letter to Michigan Board of Pharmacy Issued 02/25/2014, Referral Letter to the California State Board of Pharmacy Issued 04/05/2017, Referral Letter to the Colorado State Board of Pharmacy Issued 04/14/2020, Referral Letter to the FloridaBoard of Pharmacy Issued 07/27/2022, Referral Letter to the Ohio State Board of Pharmacy Issued 09/12/2019, Referral to the New York State Board of Pharmacy Issued 06/15/2017. (Dawson, Rian) (Entered: 04/09/2021), Docket(#18) MOTION to Dismiss Plaintiff's Amended Complaint by Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. 12. In fact, AIS contends that the Agreement expressly authorizes it to use S9328 code when it provides "professional pharmacy services" in the form of specially compounded medication to BCBS's subscribers, and therefore AIS did not breach the Agreement. AIS argues that BCBS and AHS identified no provision in the Agreement that requires it to personally fill/refill the pumps or provide ongoing services. [57] at 16. If you do not agree with these terms, then do not use our website and/or services. (Court Reporter/Transcriber: Sheri Ward, www.transcriptorders.com) (Number of Pages: 21) The parties have 21 days to file with the court and Court Reporter/Transcriber a Redaction Request of this transcript. ORDER KRISTI H. JOHNSON, District Judge. Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. No. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), (#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. The Court denies AIS's motion on this claim. AIS moves to dismiss BCBS and AHS's counter claims under Rule 12(b)(6). The Agreement's terms and conditions required AIS to submit a claim form that included a charge for home infusion therapy with the corresponding AHS-defined Healthcare Common Procedure Coding System ("HCPCS") procedure codes. [21-30534] (Charles H. Spencer-Davis ) [Entered: 09/13/2021 04:12 PM], APPEARANCE FORM FILED by Attorney(s) Imad Sayed Matini for party(s) Appellee Bond Pharmacy, Incorporated, in case 21-30534. 2005) (citation omitted). The plausibility standard does not ask for a probability of unlawful conduct but does require more than a "sheer possibility." Want justice!? Founders Chuck Bell Operating Status Active Company Type For Profit Phone Number 601.988.1700 AIS Healthcare is the provider of targeted drug delivery and infusion care. Finally, one place to get all the court documents we need. Id. Transcript Order ddl satisfied. 19 Guaynabo, PR 00966 Phone (787) 783-2245 Fax (787) 523-1178 / (787) 781-8384. 25. Appeal from the United States District Court . Court: on CaseMine. (Entered: 01/28/2021), (#5) NOTICE of Appearance by I. W. Winsten on behalf of Bond Pharmacy, Inc. d/b/a Advanced Infusion Solutions. Signed by District Judge Denise Page Hood. See Se Med. 1:19-CV-00394 | 2019-05-17, U.S. District Courts | Civil Right | R. Civ. 2018) (quoting Bus. Ct. App. (Attachments: #1 Exhibit Exhibit 1) (Knapp, Scott) (Entered: 04/28/2021), Docket(#20) NOTICE OF HEARING BY VIDEO CONFERENCE on #18 MOTION to Dismiss Plaintiff's Amended Complaint. Cause No. [21-30534] (Beau Camel ) [Entered: 09/28/2021 10:10 AM], APPEARANCE FORM FILED by Attorney(s) Beau Camel for party(s) Appellant Randy Denning, in case 21-30534. (Attachments: #1 Index of Exhibits, #2 Exhibit 1 - Home Infusion Therapy Facility Participation Agreement, #3 Exhibit 2 - October 6, 2020 Letter from M. Martinez to J. Finley, #4 Exhibit 3 - October 16, 2020 Letter from P. Werner to M. Martinez) (Winsten, I.) We engage with your physician to offer the highest standard of care. (dba Rxtra Solutions), Southfield, MI- 503A Facility, Beacon Prescriptions (see DCA Inc.), Southington, CT- 503A Facility, Bedford Pharmacy, Inc. (dba Mytilini Enterprises LLC), Bedford, NH- 503A Facility, Bella Pharmaceuticals, Inc., Glenview, IL- 503A Facility - Ceased Compounding Operations, Bellevue Pharmacy Solutions, St Louis, MO- 503A Facility, Belmar Pharmacy, Lakewood, CO- 503A Facility, Belmar Select Outsourcing, (see BSO, LLC), Lakewood, CO- 503B Facility, Best Value Drug, (see Farmville Discount Drug, Inc.), Farmville, NC- 503A Facility, Bhaumik Diversified LLC dba Texas Star Pharmacy, Dallas, TX- 503A Facility, Biomed PA Inc. (dba Soleo Health), Sharon Hill, PA- 503A Facility, Bioscrip Infusion Services, (see HomeChoice Partners, Inc.), Augusta, GA- 503A Facility, Bioscrip Infusion Services, (see InfuScience, Inc.), Chantilly, VA- 503A Facility, BioScrip Pharmacy (NY), Inc., Lake Success, NY- 503A Facility, Blount Discount Pharmacy, Inc., Alcoa, TN- 503A Facility, Blue Ridge Pharmacy and Compounding Center, Raleigh, NC- 503A Facility, BMD Skincare, Inc., Canoga Park, CA- 503A Facility - Out of business, Bond Pharmacy, Inc. (dba Advanced Infusion Solutions), Clinton, MS- 503A Facility, Bond Pharmacy, Inc. (dba Advanced Infusion Solutions), Ridgeland, MS- 503A Facility, Boothwyn Pharmacy LLC, Kennett Square, PA- 503A Facility, Botrosons Pharmaceutical Inc., (dba Tower Pharmacy and Compounding), Mission Viejo, CA- 503A Facility, brandMD Skin Care, (see TSDR Pharmacy, Inc.), Chatsworth, CA- 503A Facility, Brookfield Pharmacy, Brookfield, CT- 503A Facility, Brookfield Medical/Surgical Supply, Inc., Brookfield, CT- 503B Facility, Brookfield Prescription Center, Inc. (dba MD Custom Rx), Brookfield, WI- 503A Facility, Brookhaven Milling Company, Brookhaven, MS, Brown's Compounding Center, Inc., Englewood, CO- 503A Facility - Out of business, BSO LLC (dba Belmar Select Outsourcing), Lakewood, CO- 503B Facility, Buderer Drug Company Inc. Avon, OH- 503A Facility, Buderer Drug Company Inc. Perrysburg, OH- 503A Facility, Buffalo Pharmacies, Inc., East Amherst, NY- 503A Facility, Burklow Pharmacy, Inc., Pace, FL- 503A Facility, California Pharmacy and Compounding Center, Newport Beach, CA- 503A Facility - De-registered as an Outsourcing Facility, California Specialty Pharmacy, Inc., Whittier, CA- 503A Facility, Cantrell Drug Company,Little Rock,AR- 503A Facility - Out of business, Cape Drugs, (see Valgene Incorporated), Annapolis, MD- 503A Facility, Carepoint Healthcare, LLC (dba Carepoint Pharmacy), Schaumburg, IL- 503A Facility, Care Solutions, Inc., Nashville, TN- 503A Facility, Carltons Dunwoody Pharmacy Corp, (dba Concord, Inc.), Dunwoody, GA- 503A Facility, Cascade Specialty Pharmacy, (see Poulsbo Compounding Pharmacy, LLC), Poulsbo, WA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Homewood, AL- 503A Facility, Central Admixture Pharmacy Services, Inc., Phoenix, AZ- 503B Facility, Central Admixture Pharmacy Services, Inc. Irvine, CA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), San Diego, CA- 503B Facility, Central Admixture Pharmacy Services (CAPS), Wallingford, CT- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Chicago, IL- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Harahan, LA- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Woburn, MA- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Livonia, MI- 503A Facility, Central Admixture Pharmacy Services, Inc., (CAPS), Kansas City, MO- 503A Facility, Central Admixture Pharmacy Services Inc. Valley View, OH- 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Allentown, PA- 503B Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Cranberry Township, PA - 503A Facility, Central Admixture Pharmacy Services, Inc. (CAPS), Horsham, PA- 503A Facility, Central Illinois Compounding, Inc. (dba Preckshot Professional Pharmacy), Peoria Heights, IL- 503A Facility, CFP Acquisitions, Inc, Tulsa, OK- 503A Facility, Chastains, Inc., (dba Owl Tri State Pharmacy), Clarkston, WA- 503A Facility, Chen Shwezin, Inc., (dba Park Compounding Pharmacy), Westlake Village, CA- 503A Facility, Cincinnati Specialty Pharmacy LLC, West Chester, OH- 503A Facility, Civic Center Pharmacy, Scottsdale, AZ- 503A Facility, Claremore Compounding Center, Inc., Claremore, OK- 503A Facility, Clark Professional Pharmacy, LLC, Ann Arbor, MI- 503A Facility, Clinical Apothecaries, Medina, OH- 503A Facility, Clinical Specialties Compounding Pharmacy, Augusta, GA- 503A Facility - Out of business, CMC Enterprise Pharmacy, Charlotte, NC- 503A Facility - Out of business, Coastal Meds, LLC., Biloxi, MS- 503A Facility, Coast Quality Pharmacy, LLC, Tampa, FL- 503A Facility, College Pharmacy Incorporated, Colorado Springs, CO- 503A Facility, Colonia Care Pharmacy, Colonia, NJ- 503A Facility, Columbia River Pharmacy, LLC, (dba Malley's Compounding Pharmacy), Richland, WA- 503A Facility, Complete Pharmacy and Medical Solutions, LLC, Miami Lakes, FL- 503A Facility -De-registered as an Outsourcing Facility, Compound Care Pharmacy, Louisville, KY- 503A Facility, Compounded Solutions in Pharmacy LLC, Monroe CT- 503A Facility, Compounding Pharmacies of Louisiana Inc. (dba Professional Arts Pharmacy), Lafayette, LA- 503A Facility, Compound Preferred LLC, Idaho Falls, ID - 503B Facility, Conrad-Marr Drug, (see McAlister Drug Corporation), Yukon, OK- 503A Facility, Conversio Health, (see Integrated Health Concepts Inc.), San Luis Obispo, CA- 503A Facility, Coram Healthcare Corp. of Indiana, Crown Point, IN- 503A Facility - Out of business, Cortez Drugs, (see A Chem Rx, LLC), Brooksville, FL- 503A Facility, Crawford's Professional Drugs, Inc., (dba Diket's Professional Drugs, Inc.), Laurel, MS- 503A Facility, CRC Pharmacy, Roswell, GA- 503A Facility, Creative Compounds, (see Oregon Compounding Centers, Inc.), Wilsonville, OR- 503A Facility, Crosbys Drugs Inc., Columbus, OH- 503A Facility, Crowder's Institutional Pharmacy LLC., dba Crowder's Long-Term Care Pharmacy, Bedford, IN- 503A Facility, CSRX Inc., (dba Rushmore Compounding Pharmacy), Rapid City, SD- 503A Facility, Curexa, (see EHT Pharmacy LLC), Egg Harbor Township, NJ- 503A Facility, Customceutical Compounding, LLC, Phoenix, AZ- 503A Facility, Custom Compounding Center, Little Rock, AR- 503A Facility, Custom Compounding Centers, LLC, Los Alamitos, CA- 503A Facility, Custom Meds Inc. Inverness, FL- 503A Facility, Custom RX LLC, Wichita, KS- 503A Facility, Custom RX LLC (dba Custom RX Compounding Pharmacy), Richfield, MN- 503A Facility, D&D Pharma,LLC (dba MedScript Compounding Pharmacy), Noblesville, IN- 503A Facility, D&S Enterprises, LLC (dba Millers Health Mart Pharmacy), Vero Beach, FL- 503A Facility, Davis City Pharmacy, Inc., Weatherford, TX, DCA Inc. (dba Beacon Prescriptions), Southington, CT- 503A Facility, Delta Pharma, Inc., Ripley, MS- 503B Facility, Denson's Specialty Pharmacy, (see Wellcare Rx Investments LLC), Wheaton, IL- 503A Facility, Denver Solutions, LLC (dba Leiter's Health), Englewood, CO- 503B Facility, Designer Drugs, (see The Wellness Center Pharmacy, Inc.), Chattanooga, TN- 503A Facility, Diabetes Corporation of America, Franklin, TN- 503A Facility, Diamond Drugs, Inc., (dba Diamond Pharmacy Services), Indiana, PA- 503A Facility, Diamond Pharmacy, LLC, Houston, TX- 503A Facility, Dignity Health- Northridge Hospital Medical Center, Northridge, CA- 503A Facility, Diket's Professional Drugs, Inc., (see Crawford's Professional Drugs, Inc.), Laurel, MS- 503A Facility, Diplomat Pharmacy, Inc. (dba Diplomat Specialty Pharmacy), Flint, MI- 503A Facility, Diversified Pharmacy Inc., (dba University Compounding Pharmacy), Troy, MI- 503A Facility, DNA Pharmacy Services, Inc. (dba Palm Beach Compounding), Jupiter, FL- 503A Facility - Ceased sterile compounding, Dorneyville Pharmacy, Allentown, PA- 503A Facility, Dougherty's Pharmacy, Dallas, TX- 503A Facility, Downing Labs, LLC, (formerly NuVision Pharmacy), Dallas, TX- 503A Facility - Out of business, D.R.

Tecumseh High School Football Field, Articles A